Jay K. Trautman
Vorstandsvorsitzender bei Invenio Imaging, Inc.
Profil
Jay K.
Trautman is the founder of Photoswitch Biosciences, Inc. (founded in 2010) where he serves as Chief Executive Officer.
He is currently the President, Chief Executive Officer & Director of Invenio Imaging, Inc. (since 2012) and a Director at GenEncap, Inc., Photoswitch Therapeutics, Inc., and Vedere Bio II, Inc. He previously served as Chief Executive Officer at Praelux, Inc. (2000-2002) and Vice President-Discovery Research & Technology at Cytokinetics, Inc. (2002-2008).
He also worked as a Principal at SEQ Ltd.
Dr. Trautman received his undergraduate degree from the University of Washington and his doctorate from Cornell University.
Aktive Positionen von Jay K. Trautman
| Unternehmen | Position | Beginn |
|---|---|---|
GenEncap, Inc.
 GenEncap, Inc. Medical SpecialtiesHealth Technology GenEncap, Inc. develops and commercializes DNA sequencing technology. It offers proprietary technologies and massively-parallel sanger sequencing. The company was founded by Kevin M. Ulmer on June 19, 2007 and is headquartered in Providence, RI. | Direktor/Vorstandsmitglied | 25.03.2010 |
Invenio Imaging, Inc.
 Invenio Imaging, Inc. Hospital/Nursing ManagementHealth Services Invenio Imaging, Inc. provides treatment for cancer through label-free chemical imaging and fiber-laser technology. Its NIO Imaging System is designed to streamline intraoperative histology, reducing downtime in the OR and allowing examination of specimens from multiple sites in the surgical cavity. The company was founded in 2012 and is headquartered in Santa Clara, CA. | Vorstandsvorsitzender | 01.01.2012 |
Photoswitch Therapeutics, Inc.
 Photoswitch Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Photoswitch Therapeutics, Inc. operates as biotechnology company. The company was founded in 2017 and is headquartered in Menlo Park, CA. | Präsident | - |
Vedere Bio II, Inc.
 Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jay K. Trautman
| Unternehmen | Position | Ende |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 30.09.2008 |
Praelux, Inc.
 Praelux, Inc. Medical SpecialtiesHealth Technology Part of GE Healthcare Technologies, Inc., Praelux, Inc. is a company that develops secondary drug screening technologies. The company is based in Lawrenceville, NJ. The company was founded by Bob F. Johnston. Praelux was acquired by Amersham Pharmacia Biotech, Inc. on February 16, 2000. | Präsident | 01.06.2002 |
Photoswitch Biosciences, Inc.
 Photoswitch Biosciences, Inc. BiotechnologyHealth Technology Photoswitch Biosciences, Inc. creates advanced tools to drive next-generation membrane biology discoveries. Its products include bolt and PhoS VSD. The company was founded by Jay Trautman, Andy Blatz, Jonathan Ross, Ehud Isacoff, Richard Kramer and Dirk Trauner and is headquartered in Cleveland, OH. | Vorstandsvorsitzender | - |
| SEQ Ltd. | Corporate Officer/Principal | - |
Ausbildung von Jay K. Trautman
| University of Washington | Undergraduate Degree |
| Cornell University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Praelux, Inc.
Praelux, Inc. Medical SpecialtiesHealth Technology Part of GE Healthcare Technologies, Inc., Praelux, Inc. is a company that develops secondary drug screening technologies. The company is based in Lawrenceville, NJ. The company was founded by Bob F. Johnston. Praelux was acquired by Amersham Pharmacia Biotech, Inc. on February 16, 2000. | Health Technology |
GenEncap, Inc.
GenEncap, Inc. Medical SpecialtiesHealth Technology GenEncap, Inc. develops and commercializes DNA sequencing technology. It offers proprietary technologies and massively-parallel sanger sequencing. The company was founded by Kevin M. Ulmer on June 19, 2007 and is headquartered in Providence, RI. | Health Technology |
Invenio Imaging, Inc.
Invenio Imaging, Inc. Hospital/Nursing ManagementHealth Services Invenio Imaging, Inc. provides treatment for cancer through label-free chemical imaging and fiber-laser technology. Its NIO Imaging System is designed to streamline intraoperative histology, reducing downtime in the OR and allowing examination of specimens from multiple sites in the surgical cavity. The company was founded in 2012 and is headquartered in Santa Clara, CA. | Health Services |
Photoswitch Biosciences, Inc.
Photoswitch Biosciences, Inc. BiotechnologyHealth Technology Photoswitch Biosciences, Inc. creates advanced tools to drive next-generation membrane biology discoveries. Its products include bolt and PhoS VSD. The company was founded by Jay Trautman, Andy Blatz, Jonathan Ross, Ehud Isacoff, Richard Kramer and Dirk Trauner and is headquartered in Cleveland, OH. | Health Technology |
Photoswitch Therapeutics, Inc.
Photoswitch Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Photoswitch Therapeutics, Inc. operates as biotechnology company. The company was founded in 2017 and is headquartered in Menlo Park, CA. | Commercial Services |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | Commercial Services |
| SEQ Ltd. |
